These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
454 related articles for article (PubMed ID: 24345488)
1. [Value of surgery for stage IIIa non-small cell lung cancer]. Liu H; Wang M; Hu K; Xu Y; Ma M; Zhong W; Zhao J; Li L; Wang H Zhongguo Fei Ai Za Zhi; 2013 Dec; 16(12):639-45. PubMed ID: 24345488 [TBL] [Abstract][Full Text] [Related]
2. [Postoperative survival of patients with stage IIIa non-small cell lung cancer]. Liu H; Xu Y; Wang M; Hu K; Ma M; Zhong W; Zhang L; Zhao J; Li L; Wang H Zhongguo Fei Ai Za Zhi; 2013 Nov; 16(11):596-602. PubMed ID: 24229626 [TBL] [Abstract][Full Text] [Related]
3. Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR). Reymen B; van Baardwijk A; Wanders R; Borger J; Dingemans AM; Bootsma G; Pitz C; Lunde R; Geraedts W; Lambin P; De Ruysscher D Radiother Oncol; 2014 Mar; 110(3):482-7. PubMed ID: 24444527 [TBL] [Abstract][Full Text] [Related]
4. Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer. Zheng D; Ye T; Hu H; Zhang Y; Sun Y; Xiang J; Chen H J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1814-1822.e4. PubMed ID: 29221745 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes of Selected Patients with IIIA-N2 Non-small Cell Lung Cancer Receiving Upfront Surgical Resection. Fu F; Sun W; Bai J; Deng C; Zheng D; Li Y; Zhang Y; Chen H Ann Surg Oncol; 2023 Dec; 30(13):8261-8270. PubMed ID: 37644250 [TBL] [Abstract][Full Text] [Related]
7. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE). Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789 [TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of AJCC TNM Staging 7th edition in limited-stage small cell lung cancer: validation in 437 patients]. Zhang W; Zhu H; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Wang L Zhonghua Zhong Liu Za Zhi; 2015 Dec; 37(12):917-22. PubMed ID: 26887621 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society). Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394 [TBL] [Abstract][Full Text] [Related]
10. Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins. Yuan M; Men Y; Kang J; Sun X; Zhao M; Bao Y; Yang X; Sun S; Ma Z; Wang J; Deng L; Wang W; Zhai Y; Liu W; Zhang T; Wang X; Bi N; Lv J; Liang J; Feng Q; Chen D; Xiao Z; Zhou Z; Wang L; Hui Z Thorac Cancer; 2021 Jan; 12(2):227-234. PubMed ID: 33247556 [TBL] [Abstract][Full Text] [Related]
11. The multimodal management of locally advanced N2 non-small cell lung cancer: is there a role for surgical resection? A single institution's experience. Bosch-Barrera J; García-Franco C; Guillén-Grima F; Moreno-Jiménez M; López-Picazo JM; Gúrpide A; Pérez-Gracia JL; Aristu J; Torre W; García-Foncillas J; Gil-Bazo I Clin Transl Oncol; 2012 Nov; 14(11):835-41. PubMed ID: 22855163 [TBL] [Abstract][Full Text] [Related]
12. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery. Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175 [TBL] [Abstract][Full Text] [Related]
13. The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy. Yang H; Wang K; Li S; Li Y; Yuan L Pathol Oncol Res; 2021; 27():1609898. PubMed ID: 34447289 [No Abstract] [Full Text] [Related]
14. Is There a Survival Benefit in Patients With Stage IIIA (N2) Non-small Cell Lung Cancer Receiving Neoadjuvant Chemotherapy and/or Radiotherapy Prior to Surgical Resection: A Systematic Review and Meta-analysis. Xu YP; Li B; Xu XL; Mao WM Medicine (Baltimore); 2015 Jun; 94(23):e879. PubMed ID: 26061306 [TBL] [Abstract][Full Text] [Related]
15. Comparison on the Effect and Complications of VATS and Radical Thoracotomy for Lung Cancer in the Treatment of Stages IIB-IIIA Non-Small Cell Lung Cancer. Qian B; Song X; Chen Z; Shi M Altern Ther Health Med; 2024 Mar; 30(3):90-96. PubMed ID: 37883749 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy. Lee VH; Chan WW; Lee EY; Choy TS; Ho PP; Leung DK; Lam KO; Kwong DL; Leung TW; Khong PL Am J Clin Oncol; 2016 Aug; 39(4):355-62. PubMed ID: 24710123 [TBL] [Abstract][Full Text] [Related]
17. Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer. Finkle JH; Jo SY; Ferguson MK; Liu HY; Zhang C; Zhu X; Yuan C; Pu Y Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1275-1284. PubMed ID: 28265739 [TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society). Couñago F; Rodriguez de Dios N; Montemuiño S; Jové-Teixidó J; Martin M; Calvo-Crespo P; López-Mata M; Samper-Ots MP; López-Guerra JL; García-Cañibano T; Díaz-Díaz V; de Ingunza-Barón L; Murcia-Mejía M; Alcántara P; Corona J; Puertas MM; Chust M; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Thuissard IJ; Sanz-Rosa D; Taboada B Lung Cancer; 2018 Apr; 118():119-127. PubMed ID: 29571989 [TBL] [Abstract][Full Text] [Related]
19. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. Choi NC; Carey RW; Daly W; Mathisen D; Wain J; Wright C; Lynch T; Grossbard M; Grillo H J Clin Oncol; 1997 Feb; 15(2):712-22. PubMed ID: 9053497 [TBL] [Abstract][Full Text] [Related]
20. Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience. Savic M; Kontic M; Ercegovac M; Stojsic J; Bascarevic S; Moskovljevic D; Kostic M; Vesovic R; Popevic S; Laban M; Markovic J; Jovanovic D Thorac Cancer; 2017 Sep; 8(5):393-401. PubMed ID: 28671758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]